Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms

2017/12/25 by Stefano Partelli, Emilio Bertani, Mirco Bartolomei +9 · 2 citations
Medicine · #Neuroendocrine Tumor Research Advances #Pancreatic and Hepatic Oncology Research #Lung Cancer Research Studies

paper · doi:10.1016/j.surg.2017.11.007

Citations

• Classification of Surgical Complications
• Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
• The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After

Cited by

• Controversies in NEN : An ENETS position statement on the management of locally advanced neuroendocrine neoplasia of the small intestine and pancreas without distant metastases
• PRRT for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs)